Terumo (OTCMKTS:TRUMY) Shares Gap Down – Should You Sell?

Terumo Corp. (OTCMKTS:TRUMY) gapped down before the market opened on Friday . The stock had previously closed at $14.68, but opened at $14.1101. Terumo shares last traded at $14.6050, with a volume of 4,997 shares traded.

Terumo Trading Down 0.5%

The stock’s 50 day simple moving average is $15.60 and its two-hundred day simple moving average is $16.79. The company has a debt-to-equity ratio of 0.07, a current ratio of 2.51 and a quick ratio of 1.46. The stock has a market capitalization of $21.63 billion, a PE ratio of 24.35 and a beta of 0.75.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. Terumo had a return on equity of 9.39% and a net margin of 12.35%.The business had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.75 billion.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.